top of page

OUR PUBLICATIONS

“The joy of discovery is certainly the liveliest that the mind of man can ever feel”

- Claude Bernard -

Total Academic Publications of Dr. Suprabhat Mukherjee: 
Journal Publications : 83       Book Chapter: 24      Book Published: 01       Conference Paper:16 

Research Article

                                                                                     2024
  1. Mukherjee, S. *, & Bayry, J. (2024). The Yin and Yang of TLR4 in COVID-19. Cytokine & Growth Factor Reviews. *First and corresponding author. IF: 9.3

  2. Mukherjee, S. *, Chakraborty, A., Chakraborty, P., Gorai, S., Dutta, D. (2024). Exploring the roles of TLR4 in Human Health and Diseases: Our Experiences. ImmunoCONNECT. *First and corresponding author.

  3. Behzadi, P., Chandran, D., Chakraborty, C., Bhattacharya, M., Saikumar, G., Dhama, K., Chakraborty, A., Mukherjee, S.*, Sarshar, M. (2024). Protective and pathogenic roles of Toll-Like Receptors in COVID-19: Immunobiological Perspectives. International Journal of Biological Macromolecules (Revision Submitted). *Corresponding author. IF: 7.7

  4. Patra, R., Sen Gupta, P.S., Panda, S.K., Rana, M.K., Mukherjee, S.* (2024). Comparative binding efficacy of Ivermectin and Remdesivir against the spike protein of Omicron variants: an in-silico perspective. Indian Journal of Biochemistry & Biophysics (Revision Submitted). *Corresponding author. IF: 1.5

  5. Chakraborty, A., Midde, A., Chakraborty, P., Adhikary, S., Kumar, S., Arri, N., Das, N.C., Sen Gupta, Banerjee, A., & Mukherjee, S.* (2024). Revisiting luteolin against the mediators of human metastatic colorectal carcinoma: a biomolecular approach. Journal of Cellular Biochemistry. DOI: https://doi.org/10.1002/jcb.30654. *Corresponding author. IF: 3.0

  6. Kaur, A., Kumar, A., Kumari, G., Muduli, R., Das, M., Kundu, R., Mukherjee, S. & Majumdar, T. (2024). Rational design and computational evaluation of a multi-epitope vaccine for Monkeypox Virus: Insights into binding stability and immunological memory. Heliyon. 10:e36154. DOI: https://doi.org/10.1016/j.heliyon.2024.e36154. IF: 3.4

  7. Chakraborty, A., Bayry, J., & Mukherjee, S.* (2024). Helminth-derived biomolecules as potential therapeutics against Ulcerative Colitis. Immunotherapy. DOI: https://doi.org/10.1080/1750743X.2024.2360382. *Corresponding author. IF: 2.7

  8. Das, N.C., Gorai, S., Sen Gupta, P.S., Panda, S.K., Rana, M.K., & Mukherjee, S.* (2024). Immune targeting of filarial glutaredoxin through a multi-epitope peptide-based vaccine: a reverse vaccinology approach. International Immunopharmacology. 133:112120. DOI: https://doi.org/10.1016/j.intimp.2024.112120. *Corresponding author. IF: 4.8

Book Chapters

                                                                                     2024

  1. Mukherjee, N., Dey, S., Modak, B. K., & Mukherjee, S. * (2024). Nanomaterialien und Nanogeräte zur Behandlung von menschlichen Infektions-und Entzündungskrankheiten: Fluch oder Segen für die menschliche Gesundheit?. In Intelligente Nano-Bio-Geräte der nächsten Generation (pp. 133-162). Singapore: Springer Nature Singapore. *Corresponding author.

  2. Mondal, S., Ray, A. S., Chakraborty, A., and Mukherjee, S.*. (2024). Molecular mechanisms of action of spike glycoprotein inhibitors from traditional herbal medicines. In: Traditional and Herbal Medicines for COVID-19 (CRC Press) (Accepted). *Corresponding author.

  3. Dey, A., Goswami, D., Brahma, S., Chakraborty, A., and Mukherjee, S.*. (2024). In-silico and integrated pharmacology approaches for developing therapeutics for treating infectivity and immunopathogenesis of SARS-CoV-2: an overview. In: Integrative Omics and System s Pharmacology for COVID-19 (CRC Press) (Accepted). *Corresponding author.

  4. Chakraborty, A., Dhibar, S., Dey, S., Modak, B.K., Mondal, S., Oh, J. and Mukherjee, S.* (2024). Nanomaterials for diagnosing and treating human cancer: a comprehensive overview. In: Biocomposites Nanomaterials and Their Applications (Springer) (Accepted). *Corresponding author.

  5. Chakraborty, A., Mitra, S., Chatterjee, M., and Mukherjee, S.*. (2024). Recent advancements in developing nano-biosensors for treating inflammatory diseases of human: a comprehensive overview. In: Applications of Biotribology in Biomedical Systems (Springer). Chapter 03, ISBN: 978-3-031-58326-1, 605483_1_En. DOI: https://doi.org/10.1007/978-3-031-58327-8_3. *Corresponding author.

  6. Chakraborty, P., Chatterjee, M., Padma, S., Chakraborty, A., and Mukherjee, S.*. (2024). Phytochemicals as modulators of Toll-like receptors: an immunopharmacological perspective. In: Medicinal Plants and Antimicrobial Therapies (Springer Nature). Chapter 03, P-49-83. ISBN: 978-981-99-7260-9 (print), 978-981-99-7261-6 (online). DOI: https://doi.org/10.1007/978-981-99-7261-6_3. *Corresponding author.

  7. Padma, S., Das, N.C., Patra, R., Chakraborty, P., Dey, A. and Mukherjee, S.*. (2024). Omics-guided intervention strategies in combatting SARS-CoV-2: recent advancements and challenges In: Bioactive Compounds Against SARS-CoV-2 (CRC Press/Taylor & Francis Group, LLC), 1st Edition. ISBN 9781003323884. DOI: https://doi.org/10.1201/9781003323884-1 .  *Corresponding author.

Patents

  1.   Invention: Designing single potential vaccine AbhiSCoVac through immunoinformatics and immune simulation approaches (2022). Inventors: Choudhury, A., Sen Gupta, P.S., Panda, S.K., Rana, M.K., & Mukherjee, S. Patent Application No: 202231020075; Date of filing: 02/04/2022; Published in Indian Patent Journal on 06/05/2022.

  2.    Invention: A novel benign phyto-formulation IBIL-AR1 with potential anti-ulcerative colitis and anti-colorectal cancer efficacy (2024). Inventors: Mukherjee, S., Banerjee, A., Patra, R., Das, N. C., Chakraborty, P., Chakraborty, A., Czinn, S., Midde, A., & Ari, N. Patent Application No: 202431011037; Date of filing: 16/02/2024; Published in Indian Patent Journal on 01/03/2024.

Logo_KNU.jpg

Kazi Nazrul University

Integrative Biochemistry & Immunology Laboratory

WhatsApp Image 2023-01-23 at 23.16.13.jpeg

© 2023 by Dr. Suprabhat Mukherjee

  • Facebook Clean Grey
bottom of page